| dc.creator | Callado M.R.M. | |
| dc.creator | Lima J.R.C. | |
| dc.creator | Nobre C.A. | |
| dc.creator | Vieira W.P. | |
| dc.date | 2011 | |
| dc.date | 2015-06-30T20:39:43Z | |
| dc.date | 2015-11-26T14:52:54Z | |
| dc.date | 2015-06-30T20:39:43Z | |
| dc.date | 2015-11-26T14:52:54Z | |
| dc.date.accessioned | 2018-03-28T22:04:56Z | |
| dc.date.available | 2018-03-28T22:04:56Z | |
| dc.identifier | | |
| dc.identifier | Revista Brasileira De Reumatologia. , v. 51, n. 1, p. 40 - 52, 2011. | |
| dc.identifier | 4825004 | |
| dc.identifier | | |
| dc.identifier | http://www.scopus.com/inward/record.url?eid=2-s2.0-79952948449&partnerID=40&md5=427e6bfb7628d7fea7f72666cf3b1417 | |
| dc.identifier | http://www.repositorio.unicamp.br/handle/REPOSIP/108825 | |
| dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/108825 | |
| dc.identifier | 2-s2.0-79952948449 | |
| dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1254896 | |
| dc.description | Objective: To identify tuberculosis infection in rheumatic patients on infliximab by use of PPD testing prior to immunobiologic therapy. Methods: This study comprised 157 patients undergoing infliximab treatment and 734 other patients undergoing laboratory screening for tuberculosis infection originating from several services. The Mantoux technique was used for PPD testing, and an induration of at least 5 mm was considered reactive status. Results: In the infliximab group, 13% of the patients reacted to PPD, while, in the other group, 27% of the patients reacted to PPD (χ2 = 13; P = 0.0003). These patients were divided into categories: adults with chronic diseases, PPD reactivity of 22%; and other controls, PPD reactivity of 31%. This shows the heterogeneous response of that population (χ2 = 7; P < 0.009). In the infliximab group, subdivided according to pathologies [rheumatoid arthritis (RA), ankylosing spondylitis (AS), and psoriatic arthritis (PA)], different reactivity rates were observed, the lowest value occurring among RA patients: (RA x AS: OR = 0.13; CI: 0.03-0.47; χ2 = 12; P = 0.0004) and (RA × PA: OR = 0.16; CI: 0.02-1.04; χ2Yates corrected = 3.6; P = 0.05). The PPD reactivity in the RA subgroup (4%) was also lower as compared with that of the chronic patients group (22%) (OR = 0.16; CI: 0.05-0.49; χ2 = 14; P = 0.0002), even when reclassified into four subgroups: rheumatology (OR = 0.19; CI: 0.04-0.72), kidney transplantation (OR = 0.16; CI: 0.05-0.51), infectology (OR = 0.21; CI: 0.05-0.75), and other conditions (OR = 0.13; CI: 0.04-0.44). Conclusion: The low prevalence of PPD reaction in this Brazilian population, mainly in chronic patients, with the worst performance among RA patients, shwoed that the test has limited value for diagnosis of tuberculosis infection in candidates to infliximab therapy. © Elsevier Editora Ltda. | |
| dc.description | 51 | |
| dc.description | 1 | |
| dc.description | 40 | |
| dc.description | 52 | |
| dc.description | Keane, J., TNF-Blocking agents and tuberculosis: New drugs illuminate an old topic (2005) Rheumatology, 44, pp. 714-720 | |
| dc.description | Wallis, R.S., Broder, M.S., Wong, J.Y., Hanson, M.E., Beenhouwer, D.O., Granulomatosis infectious diseases associated with tumor necrosis factor antagonists (2004) Clin Infect Dis, 38, pp. 1261-1265 | |
| dc.description | Sociedade Brasileira de Reumatologia. Projeto Diretrizes da Associação Médica Brasileira e Conselho Federal de Medicina Artrite Reumatóide: Diagnóstico E Tratamento, , http://www.projetodiretrizes.org.br/projeto_diretrizes/015.pdf, Acessado em 23 de outubro de 2009 | |
| dc.description | Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection, , http://www.cdc.gov/mmwr/preview/mmwrhtml/rr4906a1.htm, Acessado em 23 de outubro de 2009 | |
| dc.description | Guidelines for using the QuantiFERON TB Gold Test For Detecting Mycobacterium Tuberculosis Infection, United States, , http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5415a4.htm, Acessado em 23 de outubro de 2009 | |
| dc.description | http://bvsms.saude.gov.br/bvs/publicacoes/manual_tuberculose_2006.pdf, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Guia para o diagnóstico, tratamento e prevenção da tuberculose, Acessado em 26 de outubro de 2009Rangel-Frausto, M.S., Ponce-De-León-Rosales, S., Martinez-Abaroa, C., Haslov, K., Tuberculosis and tuberculin quality: Best intentions, misleading results (2001) Infect Control Hosp Epidemiol, 22 (8), pp. 481-484 | |
| dc.description | Teixeira, L., Maciel, E., Dutra, M.E., Perkins, M.D., Johnson, J.L., do Valle Dettoni, V., Simultaneous comparison of reactivity to purified protein derivative RT-23 and Tubersol in health care workers in Vitória, Brazil (2000) Int J Tuberc Lung Dis, 4 (11), pp. 1074-1077 | |
| dc.description | Muñoz-Barret, J.M., Macías-Hernández, A.E., Hernández-Ramos, I., Durán-Martínez, E., Martínez-Magdaleno, R.M., Medina-Valdovinos, H., Comparative tuberculin reactivity to two protein derivatives (1996) Rev Invest Clin, 48 (5), pp. 377-381 | |
| dc.description | Keane, J., Gershon, S., Wise, R.P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W.D., Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent (2001) N Engl J Med, 345 (15), pp. 1098-1104 | |
| dc.description | Criscione, L.G., Clair, E.W., Tumor necrosis factor-alfa antagonists for the treatment of rheumatic diseases (2002) Curr Opin Rheumatol, 14, pp. 204-211 | |
| dc.description | Gomez-Reino, J.J., Carmona, L., Valverde, V.R., Mola, E.M., Montero, M.D., Treatment of rheumatoid arthritis with tumor necrosis factor inibitors may predispose to significant increase in tuberculosis risk: A multi center active-surveillance report (2003) Arthritis Rheum, 48, pp. 2122-2127 | |
| dc.description | Ministério Da Saúde - Programa Nacional De Controle Da Tuberculose, , http://portal.saude.gov.br/portal/saude/visualizar_texto.cfm?idtxt=28055, Acessado em 07 de outubro de 2009 | |
| dc.description | Filho, A.C., Kritski, A.L., Barreto, A.W., Lemos, A.C.M., Netto, A.R., Guimarães, C.A., II Consenso Brasileiro de Tuberculose. Diretrizes Brasileiras para Tuberculose (2004) J Bras Pneumol, 30 (1), pp. 1-55 | |
| dc.description | Façanha, M.C., Guerreiro, M.F.F., Pinheiro, A.C., Costa Lima, J.R., Vale, R.L.V., Teixeira, G.F.D., Resgate de casos subnotifcados de tuberculose em Fortaleza-CE, 2000-2002 (2003) Bol Pneumol Sanit, 11 (2), pp. 13-16 | |
| dc.description | Marques, C.D.L., Duarte, A.L.B.P., Lorena, V.M.B., Souza, J.R., Souza, W., Gomes, Y.M., Resposta atenuada ao PPD no diagnóstico de infecção tuberculosa latente em pacientes com artrite reumatóide (2009) Rev Bras Reumatol, 49 (2), pp. 121-125 | |
| dc.description | Cattamanchi, A., Dantes, R.B., Metcalfe, J.Z., Jarlsberg, L.G., Grinsdale, J., Kawamura, L.M., Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis (2009) Clin Infect Dis, 48 (2), pp. 179-185 | |
| dc.description | Jain, A., Dixit, P., Multidrug-resistant to extensively drug resistant tuberculosis: What is next? (2008) J Biosci, 33 (4), pp. 605-616 | |
| dc.description | Braga, J.U., Equivalência das Reações cutâneas do PPD entre dois produtos comercializados no Brasil (2000) Informe Epidemiológico Do SUS, , http://bvsms.saude.gov.br/bvs/periodicos/informe_epi_sus_v09_n3.pdf, Acessado em 22 de outubro de 2009 | |
| dc.description | Teixeira, L., Maciel, E., Dutra, M.E., Perkins, M.D., Johnson, J.L., do Valle Dettoni, V., Simultaneous comparison of reactivity to purified protein derivative RT-23 and Tubersol in health care workers in Vitória, Brazil (2000) Int J Tuberc Lung Dis, 4 (11), pp. 1074-1077 | |
| dc.description | Muñoz-Barret, J.M., Macías-Hernández, A.E., Hernández-Ramos, I., Durán-Martínez, E., Martínez-Magdaleno, R.M., Medina-Valdovinos, H., Comparative tuberculin reactivity to two protein derivatives (1996) Rev Invest Clin, 48 (5), pp. 377-381 | |
| dc.description | Alonso Moreno, F.J., García Bajo, M.C., Lougedo Calderón, M.J., Comas Samper, J.M., García Palencia, M., de Castro, F.L., Prevalence of tuberculosis infection among immigrants in the Toledo Health District, Spain (2004) Rev Esp Salud Publica, 78 (5), pp. 593-600 | |
| dc.description | Ostrosky-Zeichner, L., Rangel-Frausto, M.S., García-Romero, E., Vázquez, A., Ibarra, M.J., de León-Rosales, S.P., Tuberculosis in health personnel: Importance of surveillance and control programs (2000) Salud Publica Mex, 42 (1), pp. 48-52 | |
| dc.description | Kunins, H.V., Howard, A.A., Klein, R.S., Arnsten, J.H., Litwin, A.H., Schoenbaum, E.E., Validity of a self-reported history of a positive tuberculin skin test. A prospective study of drug users (2004) J Gen Intern Med, 19 (10), pp. 1039-1044 | |
| dc.description | Linquist, J.A., Rosaia, C.M., Riemer, B., Heckman, K., Alvarez, F., Tuberculosis exposure of patients and staff in an outpatient hemodialysis unit (2002) Am J Infect Control, 30 (5), pp. 307-310 | |
| dc.description | Poduval, R.D., Hammes, M.D., Tuberculosis screening in dialysis patients is the tuberculin test effective? (2003) Clin Nephrol, 59 (6), pp. 436-440 | |
| dc.description | Wauters, A., Peetermans, W.E., Van den Brande, P., de Moor, B., Evenepoel, P., Keuleers, H., The value of tuberculin skin testing in haemodialysis patients (2004) Nephrol Dial Transplant, 19 (2), pp. 433-438 | |
| dc.description | Sester, M., Sester, U., Clauer, P., Heine, G., Mack, U., Moll, T., Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients (2004) Kidney Int, 65 (5), pp. 1826-1834 | |
| dc.description | Habesoglu, M.A., Torun, D., Demiroglu, Y.Z., Karatasli, M., Sen, N., Ermis, H., Value of the tuberculin skin test in screening for tuberculosis in dialysis patients (2007) Transplant Proc, 39 (4), pp. 883-886 | |
| dc.description | Laurindo, I.M.M., Seiscento, M., Bombardia, S., Souza, T.N.L., Eluf Neto, J., Radu, A.S., Diagnosis of latent tuberculosis in rheumatoid arthritis (RA) patients: Tuberculin test (PPD) assessment. EULAR (2004) Rheumatoid Arthritis Clinical Aspects [THU0235], , http://www.abstracts2view.com/eular/sessionindex.php?session=2004374&day=2004, Acessado em 27 de janeiro de 2010 | |
| dc.description | Ehrenstein, M.R., Evans, J.G., Singh, A., Moore, S., Warnes, G., Isenberg, D.A., Mauri, C., Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNF-α Therapy (2004) J Exp Med, 200, pp. 277-285 | |
| dc.description | Martins, M., Lima, M., Duppre, N., Matos, H., Spencer, J., Brennan, P., The level of PPD-specifc INF- γ-producing CD4+ T cells in the blood predicts the in vivo response to PPD (2006) Tuberculosis, 87 (3), pp. 202-211 | |
| dc.description | Andrade, T.C.B., Maia, R.M., Cosgrove, C., Castelo Branco, L.R.R., BCG Moreau Rio de Janeiro - An oral vaccine aginst tuberculosis - Review (2005) Men Inst Oswaldo Cruz, 100 (5), pp. 459-465 | |
| dc.description | Maciel, E.L.N., Viana, M.C., Zeitoune, R.C.G., Ferreira, I., Fregona, G., Dietze, R., Prevalence and incidence of Mycobacterium tuberculosis infection in nursing students in Vitória, Espírito Santo (2005) Rev Soc Bras Med Trop, 38 (6), pp. 469-472 | |
| dc.description | Pilsczek, F.H., Kaufmann, S.H.E., Prevalence and predictors of positive tuberculin skin test results in a research laboratory (2008) Rev Soc Bras Med Trop, 41 (4), pp. 416-418 | |
| dc.description | Ponce de León, D., Acevedo-Vásquez, E., Sánchez-Torres, A., Cucho, M., Alfaro, J., Perich, R., Attenuated response to purifed protein derivate in patients with rheumatoid artritis: Study in a population with high prevalence of tuberculosis (2005) Ann Rheum Dis, 64, pp. 1360-1361 | |
| dc.description | Köker, I.H., Pamuk, A.-N., Karlikaya, N., Tunçbilek, N., Cakir, N., A low prevalence of purifed protein derivative test positivity in Turkish patients with rheumatoid arthritis. Association with clinical features and HRCT fndings (2007) Clin Exp Rheumatol, 25 (1), pp. 54-59 | |
| dc.description | Maciel, E.L.N., Meireles, W., Silva, A.P., Fiorotti, K., Dietze, R., Transmissão nosocomial por Mycobacterium tuberculosis nos estudantes da área de saúde em uma região de alta incidência de tuberculose, Vitória, Estado do Espírito Santo (2007) Rev Soc Bras Med Trop, 40 (4), pp. 397-399 | |
| dc.language | en | |
| dc.publisher | | |
| dc.relation | Revista Brasileira de Reumatologia | |
| dc.rights | fechado | |
| dc.source | Scopus | |
| dc.title | Low Prevalence Of Reactive Ppd Prior To Infliximab Use: Comparative Study On A Population Sample Of Hospital Geral De Fortaleza | |
| dc.type | Artículos de revistas | |
